Your choices go into the PDF (cover and captions); this bar does not.
Rebalix
Comparison report · official data side by side

CSP5 vs PSP5


CSP5Amundi Core S&P 500 UCITS ETF Acc
IE000UBAW7M3 · Equity · United States · Large cap
PSP5Amundi PEA S&P 500 UCITS ETF Acc
FR0011871128 · Equity · United States · Large cap
Open the interactive comparison on rebalix.com →

Comparison window: 14 Apr 20253 Sept 2026 (max: from the most recent launch) · currency: 🇪🇺 EUR · inflation: 🇮🇹 Italy · distributions: reinvested where declared

Report produced on 5 September 2026 · data as of the dates shown per section
Sources: official issuer documents (KID, factsheet, declared NAV series and holdings), ESMA register, ECB rates, Eurostat
Public methodology: rebalix.com/en/methodology

Informational document generated by rebalix.com — facts side by side, no recommendations. It does not constitute investment advice or investment research under Directive 2014/65/EU (MiFID II). Past performance is not indicative of future results.

RebalixCSP5 vs PSP5 · report of 5 September 2026

The funds at a glance

From official issuer documents and the ESMA register
CSP5IE000UBAW7M3Amundi Core S&P 500 UCITS ETF AccEquity · United States · Large cap
Declared index
S&P 500 Net Total Return Index
TER
0.03%
Transaction (KID)
0.01%
Fund size
21 mln EUR
Launch
10 Apr 2025
Currency
USD
Replication
Physical
Hedging
No
Holdings
504
Effective 🇮🇹 rate
26.00%
PSP5FR0011871128Amundi PEA S&P 500 UCITS ETF AccEquity · United States · Large cap
Declared index
S&P 500 Net Total Return Index
TER
0.12%
Transaction (KID)
0.00%
Fund size
1.2 mld EUR
Launch
20 May 2014
Currency
EUR
Replication
Synthetic (swap)
Hedging
No
Holdings
79
Effective 🇮🇹 rate

Tracking difference — year by year

Fund minus index, from issuer-declared series (complete calendar years). Each measures adherence to its OWN index.
CSP5n/d
not honestly computable
PSP53y avg: +0.07%/anno
2025
−0.09%
2024
+0.03%
2023
+0.27%
2022
+0.17%
2021
+0.34%
2020
+0.52%
Rebalix · CSP5 vs PSP5section 1 of 4
RebalixCSP5 vs PSP5 · report of 5 September 2026
CSP5Amundi Core S&P 500 UCITS ETF Acc · IE000UBAW7M3 · Equity · United States · Large cap
PSP5Amundi PEA S&P 500 UCITS ETF Acc · FR0011871128 · Equity · United States · Large cap

Performance over the period, in euro

From 14 Apr 2025 to 3 Sept 2026 · base 100 · ECB rates, dividends reinvested where declared
In euro (nominal)
10014497142142
In today’s purchasing power (net of Italy inflation)
10014497139139
CSP5PSP5
Same scale in both panels: the gap between endpoints is Italian inflation over the period (Eurostat). Volatility stays nominal, as everywhere on the site.

How far they fell — drawdown from peak (nominal)

In euro · distance from the previous peak, day by day, on NAV: for distributing classes it includes ex-dividend drops (slightly deeper than total return)
0%-2%-4%-6%-8%-10%CSP5PSP52026trough CSP5: −7.5% · 30 Mar 2026trough PSP5: −7.5% · 27 Mar 2026
Filled area: CSP5; thin lines: the other funds.
The worst episode, fund by fund
FundMax drawdownTroughRecovery timeUnderwater
CSP5−7.5%30 Mar 202617 days97 days · back to break-even on 16 Apr 2026
PSP5−7.5%27 Mar 202620 days90 days · back to break-even on 16 Apr 2026
"Recovery time" = the climb only: trough to break-even (0%). "Underwater" = decline + recovery: peak to break-even.

Drawdown net of Italy inflation

Same curve in purchasing-power terms: as on the site, drawdown follows the real view (volatility stays nominal, per methodology)
0%-2%-4%-6%-8%-10%CSP5PSP52026trough CSP5: −9.5% · 30 Mar 2026trough PSP5: −9.5% · 27 Mar 2026
In real terms declines are deeper and recoveries slower. Monthly price index (Eurostat), held at the last published value.
Rebalix · CSP5 vs PSP5section 2 of 4
RebalixCSP5 vs PSP5 · report of 5 September 2026
CSP5Amundi Core S&P 500 UCITS ETF Acc · IE000UBAW7M3 · Equity · United States · Large cap
PSP5Amundi PEA S&P 500 UCITS ETF Acc · FR0011871128 · Equity · United States · Large cap

Geographic composition

% of portfolio, from full declared holdings
CSP5PSP5United States100.0%32.7%Germany0.0%41.4%Netherlands0.0%7.5%France0.0%6.7%

Sector composition

GICS sectors, same sources and dates
CSP5PSP5Information Technology37.7%23.3%Financials12.2%14.2%Communication Services9.5%4.1%Health Care9.4%10.2%Consumer Discretionary9.0%9.5%Industrials8.2%20.4%Consumer Staples4.5%0.8%Energy3.6%2.0%

Portfolio overlap

23 common holdings · ticker match on full official portfolios
25%50%75%100%Weight of common holdings in CSP535.4%Weight of common holdings in PSP534.6%Truly shared part (duplicated investment)14.0%
How the shared part is computed: for each security held by both funds, only the SMALLER of the two weights counts — a stock at 5% in one fund and 1% in the other overlaps by 1%, not 5%. Summed over all 23 common holdings this gives 14.0%: buying both funds, roughly this share of your money buys the same stocks twice. Matching uses the ISIN of each security, as published by both issuers in their baskets.
Rebalix · CSP5 vs PSP5section 3 of 4
RebalixCSP5 vs PSP5 · report of 5 September 2026

Full comparison table

"—" = not published by the source, never estimated
CSP5Amundi Core S&P 500 UCITS ETF Acc · IE000UBAW7M3 · Equity · United States · Large cap
PSP5Amundi PEA S&P 500 UCITS ETF Acc · FR0011871128 · Equity · United States · Large cap
MetricCSP5PSP5Note
Identity
CategoryEquity · United States · Large capEquity · United States · Large capRebalix engine classification
ReplicationPhysicalSynthetic (swap)as declared by the issuer
Currency hedgingNoNosource: class name, factsheet
Income policyaccumulatingaccumulating
Costs
TER0.03%0.12%from the KID
Transaction costs (KID)0.01%0.00%internal
All-in cost0.04%0.12%TER + transaction
Tracking difference (3a)+0.07%vs its OWN index
Performance in euro (ECB rates)
1 year+22.2%+22.1%
3 years+64.0%
5 years+84.0%
10 years+293.5%— = series younger than the window
Risk · last 3 years
Volatility (ann.)+15.80%
Max drawdown−22.42%
Sharpe0.93risk-free = ECB MRO avg
Sortino1.32like Sharpe, downside only
Italian taxation
Effective capital-gains rate26.00%white list, current half-year
Documents & exchanges
Listing venues86ESMA register
Borsa Italiana ticker
Indicative cumulative cost: on 10,000 euro over 5 years (stated assumption: 5%/yr growth, cost = TER + transaction) ~26 euro CSP5 · ~76 euro PSP5. Broker costs not included.

Disclaimer

This document is for information only and does not constitute investment advice under Directive 2014/65/EU (MiFID II), investment research, a personal recommendation, or an offer or solicitation to buy or sell financial instruments.

Past performance is not indicative of, nor a guarantee of, future results. The value of an investment can go down as well as up and investors may not get back the capital invested. Euro returns are affected by currency fluctuations.

Before any investment decision, read the KID and the Prospectus, available from the issuers. Tax treatment depends on individual circumstances and may change.

Data come from official issuer documents and public registers, following the public methodology at rebalix.com/en/methodology. "—" fields were not published by the source and have not been estimated. Rebalix receives no compensation from the issuers mentioned.

Rebalix · CSP5 vs PSP5section 4 of 4